Advertisement

Ads Placeholder
Loading...

Sera Prognostics, Inc.

SERANASDAQ
Healthcare
Medical - Diagnostics & Research
$2.01
$-0.06(-2.90%)
U.S. Market opens in 19h 46m

Sera Prognostics, Inc. (SERA) Stock Overview

Explore Sera Prognostics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap76.7M
P/E Ratio-3.15
EPS (TTM)$-0.67
ROE-0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$2.52
3 Months$0.00
1 Year Target$4.22

SERA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sera Prognostics, Inc. (SERA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.20, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.22.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.15 and a market capitalization of 76.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.90%
5-Day Change
8.06%
1-Month Change
-4.74%
3-Month Change
-33.00%
6-Month Change
-38.15%
Year-to-Date (YTD) Change
-33.00%
1-Year Change
-35.78%
3-Year Change
-48.46%
5-Year Change
-83.11%
All-Time (Max) Change
-83.11%

Contact Information

801 990 0520
2749 East Parleys Way, Salt Lake City, UT, 84109

Company Facts

630 Employees
IPO DateJul 15, 2021
CountryUS
Actively Trading

Frequently Asked Questions